title: Effects of substance P and selected other neuropeptides on the synthesis of interleukin-1 beta and interleukin-6 in human monocytes: a re-examination.
abstract: Recent studies have suggested that substance P (SP) and some other neuropeptides are able to induce the synthesis of the proinflammatory cytokines interleukin-1 (IL-1) and interleukin-6 (IL-6) in peripheral blood mononuclear cells. In the present study, we re-examined these findings by using a completely endotoxin-free monocyte cultivation system. We demonstrate that the neuropeptides SP, vasoactive intestinal peptide, substance K. cholecytokinine, alpha-endorphin and beta-endorphin are consistently unable to induce the synthesis of IL-1 and IL-6 in human peripheral blood monocytes. However, low amounts of LPS (1 pg/ml) synergized with SP to induce IL-6 mRNA expression. In contrast to its lack of effect in monocytes, we were able to confirm the ability of SP to induce cytokine synthesis in astrocytic cells. Our results raise questions about previous results claiming a neuropeptide-induced synthesis of proinflammatory cytokines in human monocytes. In conjunction with other studies, we suggest that undetected levels of endotoxin/LPS in the culture medium may have been primarily responsible for results suggesting an inductive effect of neuropeptides on cytokine synthesis in monocytes.
authors.affiliation: Abteilung Psychiatrie und Psychotherapie, Universität Freiburg, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Lieb
authors.forename: B L
authors.initials: BL
authors.lastname: Fiebich
authors.forename: M
authors.initials: M
authors.lastname: Busse-Grawitz
authors.forename: M
authors.initials: M
authors.lastname: Hüll
authors.forename: M
authors.initials: M
authors.lastname: Berger
authors.forename: J
authors.initials: J
authors.lastname: Bauer
mesh_terms: D015152:Blotting, Northern; D002478:Cells, Cultured / Q000187:drug effects / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007375:Interleukin-1 / Q000096:biosynthesis* / Q000235:genetics; D015850:Interleukin-6 / Q000096:biosynthesis* / Q000235:genetics; D009000:Monocytes / Q000187:drug effects / Q000378:metabolism*; D015288:Neurokinin A / Q000494:pharmacology; D009479:Neuropeptides / Q000494:pharmacology*; D011233:Precipitin Tests; D012333:RNA, Messenger / Q000032:analysis; D012844:Sincalide / Q000494:pharmacology; D013373:Substance P / Q000494:pharmacology*; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology; D018822:alpha-Endorphin / Q000494:pharmacology; D001615:beta-Endorphin / Q000494:pharmacology
chemical_list: D007375:Interleukin-1; D015850:Interleukin-6; D009479:Neuropeptides; D012333:RNA, Messenger; D013373:Substance P; D014660:Vasoactive Intestinal Peptide; D001615:beta-Endorphin; D018822:alpha-Endorphin; D015288:Neurokinin A; D012844:Sincalide